By on August 5, 2020
Science
At Experimentica we dedicate a significant amount of state-of-the-art methods for defining a broad array of ophthalmic indications.
Capabilities
We apply deep technology expertise to successfully advance innovative ophthalmic drugs and provide quality read-outs.
Collaborative R&D projects
Together with our partners from academia and industry we are participating in a number of extramurally funded research programs among others on diabetic retinopathy, development of artificial cornea and ocular surface diseases.
By on August 5, 2020
In August 2018, Experimentica Ltd. announced the opening of a new Research & Development site in Vilnius, Lithuania, which will strengthen the company’s global position as a leader in the ophthalmic contract research organization market. The investment totaling €1.6 million was supported, in part, by a competitive award “Smart FDI”…...
By on August 5, 2020